Prion and nonprion amyloids: A comparison inspired by the yeast sup35 protein

Protein-Based Inheritance

Volumn , Issue , 2007, Pages 73-82

  Kushnirov, Vitaly V ^a   Vishnevskaya, Aleksandra B ^a   Alexandrov, Ilya M ^a   Ter Avanesyan, Michael D ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55149106204     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781498712507-12     Document Type: Chapter

References (56)

1. Horwich AL, Weissman JS. Deadly conformations — Protein misfolding in prion disease. Ceil 1997; 89:499-510.
2. Prusiner SB, Scott MR, DeArmond SJ et al. Prion protein biology. Cell 1998; 93:337-348.
3. Koo EH, Lansbury Jr PT, Kelly JW. Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci USA 1999; 96:9989-9990.
4. Fowler DM, Koulov AV, Alory-Jost C et al. Functional amyloid formation within mammalian tissue. PLoS Biol 2005; 4:e6.
5. Si K, Lindquist S, Kandel ER. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 2003; 115:879-891.
6. Wickner RB. [URE3] as an altered Ure2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264:566-569.
7. Coustou V, Deleu C, Saupe S et al. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 1997; 94:9773-9778.
8. +] prion in Saccharomyces cerevisiae. Genetics 1997; 147:507-519.
9. Bradley ME, Edskes HK, Hong JY et al. Interactions among prions and prion “strains” in yeast. Proc Natl Acad Sci USA 2002; 99 Suppl 4:16392-16399.
10. Sondheimcr N, Lindquist S. Rnql: An epigenetic modifier of protein function in yeast. Mol Cell 2000; 5:163-172.
11. Santoso A, Chien P, Osherovich LZ et al. Molecular basis of a yeast prion species barrier. Cell 2000; 100:277-288.
12. +]. Cell 2001; 106:171-182.
13. +] in the yeast Saccharomyces cerevisiae. Genetics 1994; 137:671-676.
14. +j prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375-1386.
15. Liu JJ, Sondheimer N, Lindquist SL. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSP], Proc Natl Acad Sci USA 2002; 99(Suppl 4): 16446-16453.
16. +] prions. Mol Microbiol 2004; 51:1649-1659.
17. Ter-Avanesyan MD, Kushnirov W, Dagkesamanskaya AR et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two nonoverlapping functional regions in the encoded protein. Mol Microbiol 1993; 7:683-692.
18. +], a prion- like form of release factor eRF3. EMBO J 1999; 18:1182-1191.
19. +] prion generation in yeast: Characterization of the “strain” difference. Yeast 2001; 18:489-497.
20. Coschigano PW, Magasanik B. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol Cell Biol 1991; 11:822-832.
21. Patino MM, Liu JJ, Glover JR et al. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622-626.
22. +], a heritable prion-like factor of S. cerevisiae. Cell 1997; 89:811-819.
23. King CY, Tittmann P, Gross H et al. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 1997; 94:6618-6622.
24. +] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004; 101:12934-12939.
25. King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319-323.
26. Tanaka M, Chien P, Naber N et al. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323-328.
27. Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 2005; 24:3082-3092.
28. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636-49643.
29. +] form separate structures in yeast. J Biol Chem 2004; 279:51042-51048.
30. Jones GW, Tuite MF. Chaperoning prions: The cellular machinery for propagating an infectious protein? Bioessays 2005; 27:823-832.
31. +]. Science 1995; 268:880-884.
32. Moriyama H, Edskes HK, Wickner RB. [URE3] prion propagation in Saccharomyces cerevisiae: Requirement for chaperone Hsp104 and curing by overexpressed chaperone YdjIp. Mol Cell Biol 2000; 20:8916-8922.
33. Parsell DA, Kowal AS, Singer MA et al. Protein disaggregation mediated by heat-shock protein Hsp104. Nature 1994; 372:475-478.
34. Glover JR, Lindquist S. Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins. Cell 1998; 94:73-82.
35. Kushnirov VV, Ter-Avanesyan MD. Structure and replication of yeast prions. Cell 1998; 94:13-16.
36. Serio TR, Cashikar AG, Kowal AS et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000; 289:1317-1321.
37. +] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 2001; 40:1357-1369.
38. +] to [psi'] in Saccharomyces cerevisiae. Genetics 1981; 98:691-711.
39. +] of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2000; 97:240-244.
40. Ness F, Ferreira P, Cox BS et al. Guanidine hydrochloride inhibits the generation of prion “seeds” but not prion protein aggregation in yeast. Mol Cell Biol 2002; 22:5593-5605.
41. Jung G, Jones G, Masison DC. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci USA 2002; 99:9936-9941.
42. Kushnirov W, Kochneva-Pervukhova NV, Chechenova MB et al. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J 2000; 19:324-331.
43. Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 2001; 21:7035-7046.
44. +] and their prion-specific effects. Curr Biol 2000; 10:1443-1446.
45. King CY. Supporting the structural basis of prion strains: Induction and identification of [PSP] variants. J Mol Biol 2001; 307:1247-1260.
46. Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435:765-772.
47. Tanaka M, Chien P, Yonekura K et al. Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins. Cell 2005; 121:49-62.
48. Song Y, Wu YX, Jung G et al. Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication. Eukaryot Cell 2005; 4:289-297.
49. Dagkesamanskaya AR, Ter-Avanesyan MD. Interaction of the yeast omnipotent suppressors SUP1(SUP45) and SUP2(SUP35) with non-Mendelian factors. Genetics 1991; 128:513-520.
50. Salnikova AB, Kryndushkin DS, Smirnov VN et al. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its nonheritable amyloids. J Biol Chem 2005; 280:8808-8812.
51. Johan K, Westermark G, Engstrom U et al. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95:2558-2563.
52. Ghaemmaghami S, Huh WK, Bower K et al. Global analysis of protein expression in yeast. Nature 2003; 425:737-741.
53. Klein MA, Frigg R, Flechsig E et al. A crucial role for B cells in neuroinvasive scrapie. Nature 1997; 390:687-690.
54. Silveira JR, Raymond GJ, Hughson AG et al. The most infectious prion protein particles. Nature 2005; 437:257-261.
55. Lundmark K, Westermark GT, Nystrom S et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002; 99:6979-6984.
56. Xing Y, Nakamura A, Chiba T et al. Transmission of mouse senile amyloidosis. Lab Invest 2001; 81:493-499.